Innovation-focused events provide valuable opportunities for startups, investors, researchers, and industry leaders to connect, exchange ideas, and explore solutions to pressing societal challenges. For emerging biotechnology companies, these gatherings play an important role in fostering collaboration, increasing visibility, and creating pathways for growth.
On 22 and 23 September 2026, Fetalix participated in Al Andalus Innovation Venture in Seville, one of Spain's leading innovation and entrepreneurship events. Representing the company, co-founder and CEO Joana Caldeira and Project Manager Ana Carolina Monteiro joined a diverse community of innovators, investors, and technology leaders for two days of networking, discussion, and knowledge exchange.
During the event, Joana Caldeira took to the main stage to present Fetalix's vision for addressing chronic low back pain through regenerative medicine. Building on the positive reception of the initial presentation, Joana also participated in the event's Opportunities Panel, an interactive pitching session inspired by the format of The Voice. Her pitch successfully attracted the interest of three panel members, demonstrating the enthusiasm surrounding Fetalix's technology and its potential impact on healthcare.
Throughout the event, the Fetalix stand served as a meeting point for a wide range of participants, from scientifically curious visitors seeking to learn more about regenerative medicine to investors exploring emerging opportunities in the biotechnology sector. These conversations provided valuable opportunities to exchange perspectives, establish new connections, and strengthen the company's international network.
By participating in Al Andalus Innovation Venture, Fetalix was proud to represent Portugal's growing innovation ecosystem and showcase the cutting-edge research and development being carried out within the company. The event further reinforced the importance of collaboration, entrepreneurship, and scientific innovation in advancing healthcare solutions with meaningful societal impact.Fetalix would like to thank the organisers, partners, and participants for their warm welcome and for creating an inspiring environment that fostered dialogue, collaboration, and new opportunities for innovation.
September 23, 2026
